NeuroPace, Inc. (NPCE)
8.22
+0.25
(+3.14%)
USD |
NASDAQ |
Nov 17, 16:00
8.35
+0.13
(+1.58%)
After-Hours: 20:00
NeuroPace Net Income (Quarterly) : -3.298M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -3.298M |
| June 30, 2026 | -6.20M |
| March 31, 2026 | -6.689M |
| December 31, 2025 | -2.729M |
| September 30, 2025 | -4.921M |
| June 30, 2025 | -10.02M |
| March 31, 2025 | -6.589M |
| December 31, 2024 | -5.25M |
| September 30, 2024 | -5.452M |
| June 30, 2024 | -7.514M |
| March 31, 2024 | -8.925M |
| December 31, 2023 | -6.20M |
| September 30, 2023 | -7.257M |
| June 30, 2023 | -9.124M |
| Date | Value |
|---|---|
| March 31, 2023 | -10.38M |
| December 31, 2022 | -11.15M |
| September 30, 2022 | -11.78M |
| June 30, 2022 | -12.69M |
| March 31, 2022 | -11.46M |
| December 31, 2021 | -10.69M |
| September 30, 2021 | -8.083M |
| June 30, 2021 | -8.494M |
| March 31, 2021 | -8.81M |
| December 31, 2020 | -4.618M |
| September 30, 2020 | -4.126M |
| June 30, 2020 | -8.793M |
| March 31, 2020 | -6.741M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | -7.085M |
| Accuray, Inc. | 10.13M |
| Orthofix Medical, Inc. | -6.074M |
| ResMed, Inc. | 418.41M |
| Rockwell Medical, Inc. | -2.324M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 23.10M |
| Total Expenses (Quarterly) | 26.40M |
| EPS Diluted (Quarterly) | -0.096 |
| Enterprise Value | 294.73M |
| Gross Profit Margin (Quarterly) | 84.28% |
| Profit Margin (Quarterly) | -14.27% |
| Earnings Yield | -6.79% |
| Normalized Earnings Yield | -6.695 |